Estimation of dose and cancer risk to newborn from chest X-ray in South-South Nigeria: a call for protocol optimization

Distribution of Presepsin, Krebs von den Lungen 6, and Surfactant Protein A in Umbilical Cord Blood

Presepsin is an early indicator of infection, and Krebs von den Lungen 6 (KL-6) and Surfactant Protein A (SP-A) are related to the pathogenesis of pulmonary infection and fibrosis. This study aimed to establish reference intervals (RIs) of presepsin, KL-6, and SP-A levels and to evaluate the possible influence of neonatal and maternal factors on presepsin, KL-6, and SP-A levels in umbilical cord blood (UCB). Among a total of 613 UCB samples, the outliers were removed. The RIs for presepsin, KL-6, and SP-A levels were defined using non-parametric percentile methods according to the Clinical and Laboratory Standards Institute guidelines (EP28-A3C). These levels were analyzed according to neonatal and maternal factors: neonatal sex, gestational age (GA), birth weight (BW), Apgar score, delivery mode, the presence of premature rupture of membranes (PROM), gestational diabetes mellitus (GDM), and pre-eclampsia. Presepsin, KL-6, and SP-A levels showed non-parametric distributions and left-skewed histograms. The RIs of presepsin, KL-6, and SP-A levels were 64.9–428.3 pg/mL, 43.0–172.0 U/mL, and 2.1–36.1 ng/mL, respectively. Presepsin, KL-6, and SP-A levels did not show significant differences according to sex, GA, BW, Apgar score, delivery mode, PROM, GDM, and pre-eclampsia. The median level and 97.5th centile RI of KL-6 showed a slight increase with increased GA. We established RIs for presepsin, KL-6, and SP-A levels in large-scaled UCB samples. Further investigation would be needed to determine the clinical significance.

Chest X-rays of newborns in a medical facility: variation between the entrance skin dose measurements using the indirect and direct methods for clinical dose audit

PURPOSE

This study aims to determine the mean and 75th percentile entrance skin dose (ESD_cal) from anteroposterior (AP) chest X-rays using machine parameters (indirect method). Also, a comparison was made between the ESD_cal and already determined thermoluminescent dosimeter (TLD) measurements (ESD_TLD) from a previous study from the same patients' data. In addition, the results were compared to similar articles, where the direct and indirect methods were used in estimating ESD to newborns.

MATERIALS AND METHODS

The study determined the digital radiography (DR) X-ray machine output using a calibrated XR Multidetector (silicon photodiode). X-ray machine milliampere-seconds (mAs), peak kilovoltage (kVp), focus to detector distance (FDD) and focus to skin distance (FSD) were used from a previous study. The mean kVp and mAs were 56.63 (52-60) and 5.7 (5-6.3) and the patient thickness was 9.5 (8-11.5) cm.

RESULTS

The mean ESDs of the newborn between 0 and 28 days were 0.67 ± 0.09 mGy, and the 75th percentile was 0.75 mGy. The effective dose (E) for the 40 patients was 0.19 mSv and the estimated prenatal cancer risk ranged from (5-24.7) 10^-6 Sv^-1. The variation between the indirect and the direct methods for assessing ESD was 39.6 (33.7-45.1)%.

CONCLUSION

The 75th percentile ESD was the highest compared to the American College of Radiology-American Association of Physicists in Medicine-Society for Pediatric Radiology (ACR-AAPM-SPR), European Commission (EC) and United Kingdom (UK) reports. Comparison of both methods for assessing ESD was within 40% as compared to other studies. Based on the above results, the indirect method can be implemented for clinical dose audit.